Observational study of the usefulness of an iron metabolism-related molecule hepcidin as a therapeutic response biomarker in Mycobacterium tuberculosis patients.

Observational study of the usefulness of an iron metabolism-related molecule hepcidin as a therapeutic response biomarker in Mycobacterium tuberculosis patients. - Observational study of the usefulness of an iron metabolism-related molecule hepcidin as a therapeutic response biomarker in Mycobacterium tuberculosis patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016454

Enrollment

100

Registered

2015-02-05

Start date

2015-01-09

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycobacterium tuberculosis infection

Interventions

Blood sampling for hepcidin level measurement at clinical routine sampling.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals with Mycobacterium tuberculosis infection who have capability of informed consent

Exclusion criteria

Exclusion criteria: Individuals without capability of informed consent

Design outcomes

Primary

Measure	Time frame
Relation between period required for improvement in clinical symptoms or bacteriological examinations and hepcidin level.	—

Countries

Japan

Contacts

Public ContactMasaki Yamamoto

Graduate School of Medicine, Yokohama City University Department of Respirology

masakiy@yokohama-cu.ac.jp045-787-2630

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026